Ledger.Open graph →
SEC Form D · filed August 29, 2016

Zosano Pharma Corp

Offering
$7.5M
Sold
$7.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
FREMONT, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Kleanthis J. Xanthopoulos · Fremont, CADirectorJoseph P. Hagan · Fremont, CADirectorTroy J. Wilson · Fremont, CADirectorWinnie J. Tso · Fremont, CAExecBruce J. Steel · Fremont, CADirectorKonstantinos Alataris · Fremont, CAExec · DirectorRobert Collins · Greenville, SCDirectorKerri M. Reid · Toronto, Ontario, CanadaDirectorShlomit M. Dekel · Toronto, Ontario, CanadaDirectorMark T. Johnson · Englewood, COExecJohn Walker · South San Francisco, CADirectorHaley D. Lewis · Fremont, CAExecDonald D. Kellerman · Fremont, CAExecEric D. Scharin · Fremont, CAExecGeorgia D. Erbez · Fremont, CAExecNima Abbasi · NEW YORK, NYExec · DirectorRobert M. Friedland · Toronto, Ontario, CanadaDirectorMichael M. Greenberg · Toronto, Ontario, CanadaDirectorRajay Bagaria · New York, NYDirectorKirk S. Wolfe · Indianapolis, INDirectorJohn Walker · Fremont, CADirectorHaley D. Lewis · Fremont, CAExecDonald D. Kellerman · Fremont, CAExecKonstantinos Alataris · Palo Alto, CAExec · DirectorEric D. Scharin · Fremont, CAExecGeorgia D. Erbez · Fremont, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗